Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yuyi Ling"'
Autor:
Guoyou Xie, Xu-Nian Wu, Yuyi Ling, Yalan Rui, Deyan Wu, Jiawang Zhou, Jiexin Li, Shuibin Lin, Qin Peng, Zigang Li, Hongsheng Wang, Hai-Bin Luo
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 2, Pp 853-866 (2022)
N6-methyladenosine (m6A) modification is critical for mRNA splicing, nuclear export, stability and translation. Fat mass and obesity-associated protein (FTO), the first identified m6A demethylase, is critical for cancer progression. Herein, we develo
Externí odkaz:
https://doaj.org/article/4b8e146bd58b4541a8de83b4515af059
Autor:
Hongsheng Wang, Qianqian Deng, Ziyan Lv, Yuyi Ling, Xue Hou, Zhuojia Chen, Xiaoxiao Dinglin, Shuxiang Ma, Delan Li, Yingmin Wu, Yanxi Peng, Hongbing Huang, Likun Chen
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/200f8d01afb740058e0b71ccecc51fab
Autor:
Hongsheng Wang, Qianqian Deng, Ziyan Lv, Yuyi Ling, Xue Hou, Zhuojia Chen, Xiaoxiao Dinglin, Shuxiang Ma, Delan Li, Yingmin Wu, Yanxi Peng, Hongbing Huang, Likun Chen
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-17 (2019)
Abstract Background Brain metastasis (BM) is one of the principal causes of mortality for lung cancer patients. While the molecular events that govern BM of lung cancer remain frustrating cloudy. Methods The miRNA expression profiles are checked in t
Externí odkaz:
https://doaj.org/article/4d40760a22f94683ba13296d57200fbb
Autor:
Yuyi Ling, Hong-Sheng Wang, Shuibin Lin, Qin Peng, Guoyou Xie, Jiexin Li, Jiawang Zhou, Xu-Nian Wu, Zigang Li, Hai-Bin Luo, Yalan Rui, Deyan Wu
Publikováno v:
Acta Pharmaceutica Sinica B. 12:853-866
N6-methyladenosine (m6A) modification is critical for mRNA splicing, nuclear export, stability and translation. Fat mass and obesity-associated protein (FTO), the first identified m6A demethylase, is critical for cancer progression. Herein, we develo
Autor:
Xuxian Su, Wen‐Jin Wang, Qian Cao, Hang Zhang, Bin Liu, Yuyi Ling, Xiaotong Zhou, Zong‐Wan Mao
Publikováno v:
Angewandte Chemie. 134
Autor:
Xuxian Su, Wen‐Jin Wang, Qian Cao, Hang Zhang, Bin Liu, Yuyi Ling, Xiaotong Zhou, Zong‐Wan Mao
Publikováno v:
Angewandte Chemie International Edition. 61
Autor:
Yuyi Ling, Qian Cao, Xuxian Su, Bin Liu, Xiaotong Zhou, Wen-Jin Wang, Hang Zhang, Zong-Wan Mao
Publikováno v:
Angewandte Chemie International Edition. 61
An ideal cancer treatment should not only destroy primary tumors, but also improve the immunogenicity of tumor microenvironment to achieve satisfactory anti-tumor immune effect. Herein, we designed a carbonic anhydrase IX (CAIX)-anchored rhenium(I) p
Autor:
Yanxi Peng, Hong-Sheng Wang, Haisheng Zhang, Jiexin Li, Feng Chen, Yuyi Ling, Panpan An, Zihan Li, Zhuojia Chen
Publikováno v:
Oncogene. 39:4956-4969
The mechanistic action of histone deacetylase 8 (HDAC8) in cancer motility, including epithelial-mesenchymal transition (EMT), remains largely undefined. We found that the expression of HDAC8 was upregulated in breast cancer (BC) cells and tissues as
Autor:
Yu Lin, Hongsheng Wang, Jiexin Li, Nan Luo, Cheng Ming Chiang, Yuyi Ling, Zhuojia Chen, Guoyou Xie, Yanxi Peng, Feng Chen
Publikováno v:
Nucleic Acids Research
Studies on biological functions of N6-methyladenosine (m6A) modification in mRNA have drawn significant attention in recent years. Here we describe the construction and characterization of a CRISPR–Cas13b-based tool for targeted demethylation of sp
Autor:
Guoyou, Xie, Xu-Nian, Wu, Yuyi, Ling, Yalan, Rui, Deyan, Wu, Jiawang, Zhou, Jiexin, Li, Shuibin, Lin, Qin, Peng, Zigang, Li, Hongsheng, Wang, Hai-Bin, Luo
Publikováno v:
Acta pharmaceutica Sinica. B. 12(2)